0001171843-24-001460.txt : 20240319 0001171843-24-001460.hdr.sgml : 20240319 20240319171745 ACCESSION NUMBER: 0001171843-24-001460 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Colleran David CENTRAL INDEX KEY: 0001646558 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 24765004 MAIL ADDRESS: STREET 1: 600 TECHNOLOGY PARK DRIVE STREET 2: SUITE 200 CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043145961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 4 1 ownership.xml X0508 4 2024-03-15 0 0000898437 Anika Therapeutics, Inc. ANIK 0001646558 Colleran David 32 WIGGINS AVENUE BEDFORD MA 01730 0 1 0 0 EVP, General Counsel, Corp Sec 0 Restricted Stock Unit 0.00 2024-03-15 4 A 0 19345 0 A Common Stock 19345 19345 D Stock Option (Right to Buy) 27.98 2024-03-15 4 A 0 46875 0 A 2034-03-11 Common Stock 46875 46875 D Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025. Represents a 10% premium above the closing price of Anika's common stock on the date of grant. The premium priced stock options vest in three equal annual installments beginning on March 15, 2025. /s/ David Colleran 2024-03-19